FDA inspection
GenIbet Biopharmaceuticals, S.A.: FDA inspection ending Jan 21, 2025
FDA inspection 1259407 · Voluntary Action Indicated (VAI) · Oeiras
Key facts
| Inspection ID | 1259407 |
|---|---|
| Firm | GenIbet Biopharmaceuticals, S.A. |
| FEI number | 3011160795 |
| Address | Edifacio Da Instalao Piloto Do Ibet, Avenida Da Republica |
| City | Oeiras |
| Country | Portugal |
| Fiscal year | 2025 |
| Inspection end date | Jan 21, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data